The meeting comes in the backdrop of India's Covid-19 cases count that crossed the mark of 94 lakhs on Monday. This is the second all party...
Pharma major AstraZeneca, which is developing a Covid-19 vaccine with Oxford University, said on Monday that its vaccine for the novel coronavirus could be around 90%...
Dr Gagandeep Kang, who is known for his work with vaccines spoke to Scroll.in and said that since Pfizer's coronavirus vaccine is an mRNA vaccine, it...
Harsh Vardhan said the government is expecting that early next year the country will have the vaccine from maybe or more than one source.The expert groups...
Such pauses are an expected part of any clinical study, especially large studies which includes thousands of people, said Johnson& Johnson which is conducting highest profile...
Amid the race to develop a vaccine against the novel coronavirus, Health Ministry today said that India is in conversation with Russia on lines of Sputnik-V...
Maharashtra remains the hardest-hit in the pandemic, accounting for 7,03,823 cases. In a worrying indication that the COVID crisis in Delhi is far from over, the...
Under an agreement between Mexican and Argentine governments and drugmaker, AstraZeneca may start production of Oxford COVID-19 vaccine in the first quarter of 2021.
The World Health Organization said any WHO stamp of approval on a Covid-19 vaccine candidate would require a rigorous safety data review, after Russia announced on...